JayOhnson & Johnson’s Janssen COVID-19 Vaccine: CDC and FDA have recommended that Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 vaccine be used in the United States effective April 23, 2021. However, women under the age of 50 should be aware of an especially rare risk. Blood clots with low platelets after vaccination, and other COVID-19 vaccines are available where this risk has not been observed. If you have received the J&J/Jansen vaccine, Here is what you need to know. read the CDC/FDA statement.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.